Guillain-Barré syndrome
Guillain-Barré syndrome (GBS) is a rare autoimmune disorder that affects the peripheral nervous system. It is characterized by muscle weakness, tingling, and sometimes paralysis. The exact cause of GBS is unknown, but it is believed to be triggered by an infection, usually a respiratory or gastrointestinal infection. GBS can also be triggered by vaccination or surgery.
Dr. Rajiv Motiani is a senior neurologist at Neo Hospital in Noida. He is an expert in the diagnosis and treatment of GBS. Dr. Motiani has treated many patients with GBS and has contributed significantly to the field through his research and clinical work.
One of Dr. Motiani’s patients was a 25-year-old man who was admitted to Neo Hospital with symptoms of GBS. The patient had experienced weakness in his legs and difficulty walking, and had also developed tingling and numbness in his hands and feet. Dr. Motiani conducted a thorough physical examination and ordered several tests, including nerve conduction studies and electromyography (EMG). The tests confirmed a diagnosis of GBS.
Dr. Motiani immediately started the patient on intravenous immunoglobulin (IVIG) therapy. IVIG is a treatment that involves the administration of immunoglobulin (antibodies) from donated blood. It is believed to help reduce the inflammation that occurs in GBS. Dr. Motiani monitored the patient closely and adjusted his treatment as needed. Within a few days, the patient’s symptoms began to improve, and he was able to walk without assistance.
Another patient treated by Dr. Motiani was a 48-year-old woman who was admitted to Neo Hospital with similar symptoms of GBS. She had also experienced tingling and numbness in her hands and feet, as well as weakness in her legs. Dr. Motiani again conducted a thorough physical examination and ordered several tests, including nerve conduction studies and EMG. The tests confirmed a diagnosis of GBS.
Dr. Motiani started the patient on IVIG therapy and monitored her closely. However, her symptoms did not improve as quickly as expected. Dr. Motiani ordered a series of plasmapheresis treatments, which involves the removal of plasma from the blood and replacement with a plasma substitute. This treatment is believed to help remove harmful antibodies from the bloodstream. After several plasmapheresis treatments, the patient’s symptoms began to improve, and she was able to walk without assistance.
Dr. Motiani has also contributed significantly to the field of GBS through his research. He has published several papers on the diagnosis and treatment of GBS, including a study on the use of IVIG therapy in Indian patients with GBS. His research has helped to improve the understanding and treatment of GBS, both in India and around the world.
conclusion
GBS is a rare autoimmune disorder that affects the peripheral nervous system. Dr. Rajiv Motiani is a senior neurologist at Neo Hospital in Noida who has treated many patients with GBS and has contributed significantly to the field through his research and clinical work. He has helped to improve the understanding and treatment of GBS, and his patients have benefited greatly from his expertise and care.
